Indo Us Bio-Tech logo

Indo Us Bio-Tech

INDOUS NSE
₹86.84 14.47 (19.99%)
Market Cap
₹174 Cr
P/E
15.18

Indo Us Bio-Tech (INDOUS) share price was ₹86.84 at the 28 Oct 2026 close; market capitalisation ₹174 Cr; P/E (TTM) 15.18; sector FMCG. The share price fell 38.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 7.2% year on year to ₹32.99 Cr and net profit was ₹3.04 Cr, against ₹4.70 Cr a year earlier (compared with Jun 2025). Promoters held 68.29% of Indo Us Bio-Tech in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 47/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹86.84 −54.88 −38.72% 1Y

Key Fundamentals

MicrocapConsumer GoodsFMCG
Market Cap
₹174 Cr
P/E (TTM)
15.18
EBITDA
₹6.90 Cr
Return on Equity
13.15%
Debt to Equity
0.4
Book Value
₹46.15
EPS (TTM)
₹5.72
52W High
₹159.00
52W Low
₹57.50

Price-based figures as of 28 Oct 2026, 15:24 IST · EPS basis: Standalone · TTM

Peer Comparison

Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products

LT Foods
₹385.8020.9213,397 Cr2.960.77%13.83%18.52%12,166 Cr640 Cr
KRBL
₹350.6510.588,026 Cr1.381.26%11.16%14.81%6,137 Cr758 Cr
Gujarat Ambuja Exports
₹145.8316.086,689 Cr1.860.21%9.23%12.46%6,110 Cr416 Cr
Kaveri Seed Company
₹700.3514.433,603 Cr2.000.73%16.86%17.00%1,302 Cr249 Cr
Trualt Bioenergy
₹375.7520.613,222 Cr1.990.00%6.14%10.77%2,823 Cr159 Cr
GRM Overseas
₹87.3922.411,811 Cr3.020.51%12.56%20.24%1,899 Cr77 Cr
Indo Us Bio-Tech (this company)
₹86.8415.18174 Cr1.880.35%13.15%14.97%113 Cr11 Cr
Median 7 companies₹350.6516.083,603 Cr1.990.51%12.56%14.97%2,823 Cr249 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
47 Average
Overall score
Data confidence 100/100

Category scores

Quality Average 49
Returns, margins, earnings quality 22%
Valuation Weak 43
Cheap vs sector & own history 24%
Growth Weak 41
Sales & profit trajectory 9%
Financial Health Strong 73
Solvency, leverage, coverage 9%
Momentum Poor 35
Trend strength, vol-adjusted 12%
Ownership Average 55
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has delivered good profit growth of 20.8% CAGR over last 5 years
  • Debtor days have improved from 64.6 to 45.5 days.
  • Company's median sales growth is 20.7% of last 10 years

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

BearishNeutralBullish

Bullish

Bearish
4
Neutral
4
Bullish
11

Moving Averages

BearishNeutralBullish

Bullish

Bearish
2
Neutral
0
Bullish
8

Growth Rate

Revenue Growth
24.88% higher than 3Y

change over 1 year

Net Income Growth
4.08% lower than 3Y

change over 1 year

Cash Flow Change
—

EBITDA Margin Change
3.44%

change over 1 year Operating margin 12.03% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
19.14
15.81
22.11
15.77
24.72
22.17
23.56
33.38
30.77
30.85
22.8
26.02
32.99
Expenses
16.15
13.21
17.88
14.79
21.03
17.05
18.02
28.8
25.3
26.69
18.65
22.79
29.02
Operating Profit
2.99
2.6
4.23
0.98
3.69
5.12
5.54
4.58
5.47
4.16
4.15
3.23
3.97
OPM %
15.62%
16.45%
19.13%
6.21%
14.93%
23.09%
23.51%
13.72%
17.78%
13.48%
18.2%
12.41%
12.03%
Other Income
0.03
0
0.08
0.21
0.03
0.02
0.02
0.12
0
0.03
0.01
0.02
0.12
Interest
0.37
0.41
0.37
0.36
0.33
0.52
0.38
0.26
0.45
0.42
0.77
0.6
0.74
Depreciation
0.2
0.21
0.19
0.2
0.2
0.18
0.16
0.56
0.2
0.21
0.22
0.27
0.27
PBT
2.45
1.98
3.75
0.63
3.19
4.44
5.02
3.88
4.82
3.56
3.17
2.38
3.08
Tax %
3.27%
15.66%
1.87%
17.46%
0.63%
2.03%
-0.8%
4.9%
2.49%
3.09%
5.36%
17.23%
1.3%
Net Profit
2.37
1.67
3.68
0.52
3.17
4.36
5.05
3.68
4.7
3.45
3
1.97
3.04
EPS (₹)
1.18
0.83
1.84
0.26
1.58
2.17
2.52
1.84
2.34
1.72
1.5
0.98
1.52
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
20
19
24
29
35
40
39
49
61
73
104
110
113
Expenses
19
19
23
27
32
36
34
42
51
62
85
93
97
Operating Profit
1
0
1
3
3
4
6
7
9
11
19
17
16
OPM %
3.1%
2.6%
5%
9%
10%
10%
14%
14%
15%
15%
18%
15%
14%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
1
1
0
1
1
1
1
2
1
2
3
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
PBT
0
0
1
2
3
3
4
5
7
9
17
14
12
Tax %
-92%
-50%
25%
29%
26%
12%
-23%
5%
2%
6%
2%
6%
—
Net Profit
0
0
0
1
2
3
5
5
7
8
16
13
11
EPS (₹)
0.48
0.35
0.38
1.41
1.44
1.74
3.52
2.86
3.6
4.11
8.11
6.54
5.72
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
3
5
6
6
9
10
20
20
20
Reserves
1
2
2
2
9
10
15
30
44
43
58
72
Borrowings
2
5
5
7
6
9
11
12
12
14
15
37
Other Liabilities
3
6
4
6
4
10
11
4
3
7
4
4
Total Liabilities
8
14
13
17
24
35
44
56
69
84
98
133
Fixed Assets
1
1
1
2
1
1
2
6
7
7
10
11
CWIP
0
0
0
0
1
1
2
2
1
4
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
13
11
16
21
32
39
48
61
74
88
121
Total Assets
8
14
13
17
24
35
44
56
69
84
98
133
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
0
-1
-3
-1
0
3
1
2
1
-13
Investing
—
—
0
0
-3
-1
-2
-5
-7
-3
-1
-2
Financing
—
—
0
1
6
2
1
2
6
1
-1
20
Net Cash Flow
—
—
0
0
0
0
0
0
0
1
-1
6
Free Cash Flow
—
—
0
-1
-4
-1
-2
-1
-1
0
1
-15
CFO/EBITDA
—
—
11
-16
-92
-20
6
47
9
23
9
-71
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
25
107
76
112
94
193
229
152
148
95
53
45
Inventory Days
91
118
92
98
176
751
—
—
—
—
—
—
Days Payable
57
115
64
71
34
667
—
—
—
—
—
—
Cash Conversion Cycle
59
110
104
138
236
276
229
152
148
95
53
45
Working Capital Days
66
33
34
59
129
137
186
257
285
266
247
248
ROCE %
14%
7%
14%
28%
20%
17%
18%
16%
15%
14%
21%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Indo Us Bio-Tech insights

60 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

FIIs0.01%Promot.68.29%DIIs0.25%Others6.98%Public24.47%As ofSep 2026

Documents

Frequently Asked Questions about Indo Us Bio-Tech

What does Indo US Bio-Tech Ltd do?
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]
Where is Indo US Bio-Tech Ltd (INDOUS) listed?
Indo US Bio-Tech Ltd trades as INDOUS on the NSE and under code 541304 on the BSE.
Which sector does Indo US Bio-Tech Ltd belong to?
Indo US Bio-Tech Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the market capitalisation of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd has a market capitalisation of ₹174.13 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd trades at a PE ratio of 15.18 as of 28 Oct 2026, on earnings per share of ₹5.72, against a book value of ₹46.15 per share.
What is the 52-week high and low of Indo US Bio-Tech Ltd?
Over the last 52 weeks Indo US Bio-Tech Ltd has traded between ₹57.5 and ₹159 as of 28 Oct 2026.
Does Indo US Bio-Tech Ltd pay dividends?
Indo US Bio-Tech Ltd has a dividend yield of 0.35%.
What is the Return on Equity (ROE) of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd reported a return on equity of 13.15%. Its debt-to-equity ratio is 0.40.

Company Information

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

Website indousagriseeds.com
CEO Mr. Jagdishkumar Devjibhai Ajudia
Listed 2024-09-27
Face Value ₹ 10
Shares Outstanding 2,00,52,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INDOUS.md for Indo US Bio-Tech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month